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AbstrAct
Objectives Exercise-based cardiac rehabilitation (CR) 
may be beneficial to patients following transcatheter aortic 
valve implantation (TAVI) and open surgical aortic valve 
replacement (SAVR). We aimed to undertake a systematic 
review and meta-analysis to evaluate the efficacy, safety 
and costs of exercise-based CR post-TAVI and post-SAVR.
Methods We searched numerous databases, including 
Embase, CENTRAL and MEDLINE, up to October 2017. 
We included randomised controlled trials (RCTs) and 
non-randomised controlled trials (non-RCTs) of exercise-
based CR compared with no exercise control in TAVI or 
SAVR patients ≥18 years. Data extraction and risk of 
bias assessments were performed independently by two 
reviewers. Narrative synthesis and meta-analysis (where 
appropriate) were carried out for all relevant outcomes, 
and a Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) analysis was also 
performed.
Results Six studies, all at low risk of bias, were included: 
three RCTs and three non-RCTs (total of 27 TAVI, 99 
SAVR and 129 mixed patients), with follow-up of 2–12 
months. There was an increase in pooled exercise capacity 
(standardised mean difference: 0.41, 95% CI 0.11 to 0.70; 
moderate certainty evidence as assessed by GRADE), with 
exercise-based rehabilitation compared with control. Data 
on other outcomes including quality of life and clinical 
events were limited.
Conclusions Exercise-based CR probably improves 
exercise capacity of post-TAVI and post-SAVR patients in 
the short term. Well conducted multicentre fully powered 
RCTs of ≥12 months follow-up are needed to fully assess 
the clinical and cost-effectiveness of exercise-based CR in 
this patient population.
PROSPERO Protocol Registration 
Number CRD42017084716.
INtROduCtION
Heart valve disease accounts for up to a 
third of heart diseases and is very common 
within the ageing population.1 When symp-
tomatic, valve disease can have a significant 
negative effect on the patient’s ability to 
carry out daily physical activities and is also 
significantly associated with an increased 
risk of mortality and morbidity.2 The most 
effective treatment in patients with severe 
aortic stenosis has traditionally been 
surgical aortic valve replacement (SAVR).3–5 
Open surgery however often leaves people 
immobile during recovery and in particular 
sternum healing,1 requiring a significant 
period of rehabilitation and is also associ-
ated with higher risk of complications and 
Key questions
What is already known about this subject?
 ► Aortic stenosis (AS) is the single most common pri-
mary valve lesion undergoing treatment in devel-
oped countries, and it is becoming a bigger health 
problem in an ageing population. There is often a 
period of deconditioning beforehand and slow or 
incomplete recovery following transcatheter aortic 
valve implantation (TAVI) or surgical aortic valve re-
placement (SAVR). Exercise-based cardiac rehabili-
tation (CR) may facilitate the recovery of post-TAVI 
and post-SAVR patients.
What does this study add?
 ► Little is known about the impact of CR in patients 
with AS following either TAVI or SAVR. This system-
atic review and meta-analysis identified a small 
comparative evidence base that suggests exer-
cise-based CR may improve exercise capacity of 
post-TAVI and post-SAVR patients in the short term. 
However, the effect of exercise-based CR on quali-
ty of life and clinical events, such as hospitalisation 
and mortality, remains uncertain.
How might this impact on clinical practice?
 ► Although suggesting likely benefit, the results of 
this review indicate the need for more high-quality 
multicentre trials in larger post-TAVI and post-SAVR 
patient cohorts, with longer study periods to defin-
itively assess the effects of exercise-based CR in 
these patients.
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mortality in elderly patients.6 Transcatheter aortic 
valve implantation (TAVI), which is minimally inva-
sive, is therefore usually preferred in elderly or frail 
patients,6 7 but nevertheless is still associated with a 
significant period of recovery.
Cardiac rehabilitation (CR) is defined as ‘the coordi-
nated sum of activities necessary to provide patients with 
the best physical, social and mental circumstances, as well 
as make an impact on the underlying cause of cardiovas-
cular disease.8 CR seeks to enable patients to maximise 
their function and halt or reverse disease progression 
through positive changes in healthier lifestyle behaviour.8 
In addition to exercise training, comprehensive CR 
is recommended to include psychological and educa-
tion-based interventions.9 The European Society of 
Cardiology10–12 and the American College of Cardiology/
American Heart Association have given a Class I recom-
mendation for using exercise-based CR as an interven-
tion in postmyocardial infarction and heart failure.13 14
However, the impact of exercise-based CR in post-TAVI 
and post-SAVR populations remains less clear. Exer-
cise-based CR is recommended by the European Society 
of Cardiology Working Groups for selected patients after 
SAVR15 but not currently for the management of patients 
after TAVI.5 15 Previous systematic reviews of the use of 
CR after valve surgery have limitations, as they either 
focused on patients with mitral valve surgery1 and failed 
to consider recent evidence.6
This contemporary systematic review and meta-analysis 
aimed to assess the clinical effectiveness, safety and costs 
of exercise-based CR plus usual care for patients following 
SAVR or TAVI, compared with usual care only. Both 
RCTs and non-RCTs were used, and several outcomes, 
including exercise capacity, were considered.
MEtHOdS
This study was conducted according to the Cochrane 
Handbook for Systematic Reviews of Interventions16 and 
reported in line with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses reporting guide-
lines.17 The protocol for this study was registered on 
PROSPERO before the completion of full-text screening. 
This systematic review and meta-analysis did not require 
ethics approval.
data sources and searches
Searches were undertaken using a detailed search 
strategy from inception to October 2017 of the following 
databases: Cochrane Library (CENTRAL), HTA, DARE, 
MEDLINE, MEDLINE In-Process, Embase, Web of 
Science, CINAHL Plus, AMED and PEDro (see appendix 
A).  ClinicalTrials. gov and WHO’s ICTRP were also 
searched for ongoing clinical trials. Hand searching of 
the references of the included trials was also done. No 
language of publication filters or other restrictions were 
applied to the search.
Study selection
Studies for this review were considered eligible if they 
included: (1) adults (≥18 years) who had undergone 
either TAVI or SAVR, (2) who received exercise-based 
CR (as supervised/unsupervised, hospital based/home 
based, inpatient/outpatient with or without education 
and psychological interventions), (3) compared a no 
exercise control group including usual medical care; 
and (4) collected the outcomes of mortality, hospitali-
sations, health-related quality of life (HRQoL), exercise 
capacity, functional capacity, return to work, adverse 
events (safety) and cost. Studies were also included if a 
majority of participants (>50%) in a mixed valve replace-
ment population were adults and had received SAVR or 
TAVI. Studies including patients who previously attended 
defined exercise-based rehabilitation programmes were 
excluded.
Study selection was independently carried out by 
two authors (LA and PR), and all disagreements were 
discussed before contacting a third author (LL or RT) if 
no agreement was reached. Non-English language papers 
were translated.
data extraction and risk of bias assessment
Data on study characteristics (population, intervention, 
control and outcome) were extracted using a piloted data 
collection form. Risk of bias was assessed using the revised 
Cochrane Risk of Bias tool for randomised trials (ROB 
2.0),18 and the Risk of Bias In Non-randomised Studies – 
of Interventions tool.19 Assessment included: method of 
randomisation, consideration of confounders, selection 
of participants into the study, classification of interven-
tions, deviations from intended interventions, missing 
outcome data (ie, level of drop out), measurement of the 
outcome, selection of the reported result, baseline balance 
between both groups and comparable care received by 
both groups (excluding the intervention). Data extrac-
tion and risk of bias assessment were independently 
carried out for the included studies by two authors (LA 
and PR). All disagreements were resolved either through 
discussion or by consulting a third reviewer RT. Grading 
of Recommendations Assessment, Development and 
Evaluation (GRADE) analysis using GRADEpro20 was also 
undertaken by LA and checked by LL and RT, to grade 
the certainty of the available evidence and therefore help 
inform decisions based on this evidence. A starting rating 
of ‘high quality’ evidence (for RCTs and non-RCTs) was 
downgraded by one level each for risk of bias, inconsist-
ency, indirectness and imprecision and upgraded by one 
level each based on strong association, dose response and 
confounding factor effect.
Statistical analysis
Data were processed according to the Cochrane Hand-
book for Systematic Reviews of Interventions.16 Outcome data 
were transferred into the Review Manager 5 program.21 
Meta-analysis was carried out for all outcomes reported 
by two or more studies where pooling of the results was 
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Figure 1 PRISMA flow diagram showing how studies were selected for this systematic review. Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses.
possible. Dichotomous data were analysed as relative risks 
(RRs) and continuous data as mean difference (MD) if 
all studies used the same measurement scale or standard-
ised mean difference (SMD) if different scales were used. 
Data from latest follow-up were pooled across studies and 
reported as means and as 95% CIs. A fixed-effects (FE) 
model was used where there was no substantial statistical 
heterogeneity between studies. Where there was substan-
tial statistical heterogeneity (I2 statistic >50% and p 
value<0.10 for χ2 test), a random-effects (RE) model was 
used. A fixed versus random effects model meta-analysis 
was done, and the results were compared where I2 statistic 
<50% and p<0.10, or I2 statistic >50% and p>0.10. RCT 
and non-RCT outcome data were not pooled, but results 
presented using a stratified meta-analysis. Narrative 
synthesis was carried out for outcomes where meta-anal-
ysis was not possible.
RESultS
Study selection
Our electronic searches yielded 4681 titles. Following 
de-duplication and initial screening, 4619 articles were 
excluded (figure 1). Following full paper review, 55 publi-
cations were excluded. 6 studies (seven publications) 
were included in this systematic review - 3 RCTs.22–28
description of included studies
A summary of study characteristics table was made 
(table 1). Of the six studies, only five studies (six 
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Tabel 1 Summary of characteristics of studies
Studies
Pressler Sire Sibilitz Newell Jairath Landry
Study characteristics Publication year 2016 1987 2016 1980 1995 1984
Study location Germany Norway Denmark UK Canada Canada
Single/multicentre Multicentre Single centre Single centre Single centre Multicentre Single centre
Sample size 30 44 147 24 49 20
Population 
characteristics
Males (%) 15 (50) 36 (82) 112 (76) 17 (71) 34 (69) 20 (100)
Females (%) 15 (50) 8 (18) 35 (24) 7 (29) 15 (31) 0 (0)
Age range (mean/
median±SD)
81±6 45.5±12.2 62.0±11.5 39.7±5.6 55.35±10.71 53±4
Diagnosis Aortic 
regurgitation: 
intervention 
group (53%), 
control group 
(73%).
Aortic stenosis 
(27.3%), aortic 
insufficiency 
(31.8%), combined 
aortic stenosis and 
insufficiency (40.9%).
Atrial 
fibrillation: 
intervention 
(21%) and 
control (85%).
Aortic stenosis 
(25%), aortic 
regurgitation 
(8.3%), mitral 
stenosis (8.3%) 
and mitral 
regurgitation 
(8.3%).
Aortic stenosis 
(36.2%) 
and aortic 
regurgitation 
(53.2%).
Aortic stenosis 
(40%), aortic 
regurgitation 
(25%) and 
combined lesion 
(35%).
Interventional 
characteristics
Intervention type Cycle ergometer. Bicycle ergometer
+aerobic
+callisthenics.
Aerobic
+exercise 
bicycle.
Aerobic
+callisthenics.
Aerobic. Bicycle 
ergometer.
Intervention duration 
(weeks)
8 4 12 24 12 8
Intervention frequency Twice to thrice 
weekly
Daily Thrice weekly Daily Weekly Thrice weekly
Maximum follow-up 
(weeks)
8 48 24 24 25 8
Setting Centre Centre
+home
Centre
+home
Centre
+home
Centre
+home
Centre
Study type RCT RCT RCT Non-RCT Non-RCT Non-RCT
Table showing a summary of the study characteristics of the included studies.
Non-RCT, non-randomised controlled trial; RCT, randomised controlled trial; SD, Standard Deviation.
publications) provided useable outcome data.22–26 28 The 
population of the included studies was either TAVI-only 
patients (one study), SAVR-only patients (three studies) 
or a mix of TAVI or SAVR (one study). These five studies 
provided data for a total of 255 patients (99 post SAVR, 27 
post TAVI and 129 mixed). Sample size ranged from 20 
to 129 across studies. The studies were either single (four 
studies) or multicentre (two studies) and were conducted 
in Canada (two studies) or Europe (four studies). Inter-
vention duration ranged from 1 month to 6 months 
with follow-up of 2–12 months. Mean age in the studies 
ranged from 39.7 to 81.0 years, 50%–100% male. Where 
reported, a number of patients had additional cardiac 
comorbidities including coronary artery disease, heart 
failure and atrial fibrillation.23 24
Three studies22 24 26 provided CR combining both a 
supervised hospital and home-based sessions setting 
(supervised only in Jairath study), while the Pressler 
and Landry studies only used a hospital-based CR.23 28 
CR frequency varied across studies from three to seven 
sessions per week, with exercise intensity individualised 
to the patient. Varying exercise session lengths (often not 
fully reported) were also used. Exercise-based CR involved 
aerobic exercises (walking, swimming and so on), bicycle 
ergometers and callisthenics (muscle strengthening 
exercises). Home-based exercises were either aerobics or 
simple daily exercises (the Sibilitz study used an exercise 
bicycle). Only the Sibilitz study reported a cointerven-
tion of monthly psych-educational consultations.24 See 
appendix B for summary of findings table.
Risk of bias in included studies
Risk of bias for each included study was assessed based on 
the available information (see appendix C). Of the three 
included RCTs, only the Sibilitz study24 reported conceal-
ment of participant allocation. Three studies did not 
mention outcome assessment blinding.22 26 28 Only the 
Jairath study26 was judged to be at a high risk of bias for 
incomplete outcome data (ie, >20% loss to follow-up). 
Two studies were at risk of performance bias: the nature 
of care received in the Landry study28 was not reported, 
and more assistance was given only to patients in the 
intervention group but not the control to encourage 
their return to work in the Sire study.22
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Figure 2 Forest plot of comparison: exercise versus no exercise, outcome: exercise capacity (VO2 max) at maximum follow-
up, using a random-effects model stratified meta-analysis. RCTs, randomised controlled trials.
Two of the three non-RCTs had a high risk of selec-
tion bias as there was no detailed description of partic-
ipant baseline demographics in the intervention and 
control groups.26 27 There were also some concerns with 
the Landry study28 as it did not explore all the possible 
confounders (ie, age, gender, left ventricular ejection 
fractio, coexistence of mitral regurgitation and number 
of medical comorbidities).
Overall, the five included studies were considered low 
risk of bias (ie, had low risk of bias in four or more items).
Effects of intervention
Mortality and hospitalisation
No studies reported deaths or hospitalisations.
Exercise capacity
All studies reported exercise capacity as maximal oxygen 
uptake (VO2 max): four studies reporting as mL/kg/min 
and one as kj, and two studies also reported 6 min walk 
test (6MWT).23 24 Pooling all VO2 max outcomes across 
studies showed results in favour of the exercise CR (ie, RE 
RCT: SMD 0.41, 95% CI 0.11 to 0.70, GRADE: moderate 
certainty evidence; non-RCTs: SMD 0.76, 95% CI −0.26 
to 1.79, GRADE: very low certainty evidence) (figure 2). 
Pooling only studies reporting VO2 max as mL/kg/min 
also showed a benefit in favour of exercise (RE RCT: MD 
1.92, 95% CI −0.23 to 4.07, favours exercise; non-RCT: 
MD 4.59, 95% CI 1.81 to 7.37, favours exercise). Overall, 
6MWT was not statistically significant between the exer-
cise and the control groups (FE: MD 12.74, 95% CI −17.08 
to 42.56, RE: MD 22.90, 95% CI −31.64 to 77.43, GRADE: 
moderate certainty evidence) (appendix D).
Health-related quality of life
Two of the included studies reported HRQoL, using 
generic (12 or 36-Item Short Form Survey (SF-12 or 
SF-36))23 24 or disease-specific validated instruments 
(Kansas City Cardiomyopathy Questionnaire (KCCQ))23 
scales. Meta-analysis showed that there was no difference 
between the rehabilitation and control groups in SF-12/36 
scale mental component score (MD −0.44, 95% CI −3.43 
to 2.56, GRADE: moderate certainty evidence) or phys-
ical component score (MD 2.81, 95% CI −5.82 to 11.44, 
GRADE: moderate certainty evidence) (figure 3). Vote 
counting showed HRQoL scores at follow-up generally in 
favour of CR (appendix E).
Functional capacity
Only Sibilitz reported functional capacity (appendix F). 
At 4-month follow-up postrandomisation, both exercise 
and control each had 46 patients in the New York Heart 
Association class I (p=0.59, 95% CI not reported).
Return to work
Only the Sire study reported this outcome (appendix G). 
At 12-month post operation, 17 of 21 (81%) patients in 
the exercise group and 15 of 23 (65%) patients in the 
control group had returned to work. P value not reported.
Adverse effects
Safety outcomes were reported inconsistently across 
studies (appendix H). Sibilitz reported 11/72 (15.3%) 
patients with adverse events in the exercise group 
compared with 3/75 (4%) patients in the control group. 
The studies of Pressler, Sibilitz and Sire reported a total of 
5 out of 108 (4.6%) patients experienced serious adverse 
events in the exercise group compared with 3/113 
(2.7%) in the control group (RR 1.65, 95% CI 0.44 to 
6.18, GRADE: low certainty evidence). Sire and Pressler 
together reported overall drop out due to adverse events 
as 2/36 (5.6%) in the intervention group versus 2/38 
(5.3%) in the control group (RR 1.05, 95% CI 0.05 to 
22.62 [RE] and 0.21–5.11 [FE], GRADE: low certainty 
evidence).
Costs
Only Sibilitz reported costs (appendix I) and reported 
no statistically significant difference in the mean total 
copyright.
 o
n
 O
ctober 29, 2019 at University of Exeter. Protected by
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000922 on 9 April 2019. Downloaded from
 
Open Heart
6 Anayo L, et al. Open Heart 2019;6:e000922. doi:10.1136/openhrt-2018-000922
Figure 3 Forest plot of comparison: exercise versus no exercise, outcome: HRQoL (A) mental component (fixed-effects meta-
analysis) and (B) physical component (random-effects meta-analysis). Overall, there is no statistically significant difference 
between both groups.
societal costs (ie, CR: €14 185 vs control: €17448, mean 
group difference was €−1609, 95% CI: €−6162 to €2942).
dISCuSSION
This systematic review and meta-analysis aimed to eval-
uate the efficacy, safety and costs of exercise-based CR 
in TAVI or SAVR patients. In addition to RCTs, we also 
included non-RCTs to allow us evaluate the safety of the 
intervention. Our results showed probable improvement 
in exercise capacity in favour of the exercise-based CR 
compared with no exercise across the studies. However, 
there was insufficient evidence to comment on the impact 
of exercise-based CR on HRQoL, mortality, hospitalisa-
tions, functional capacity, return to work or costs. There 
was also not enough evidence to allow us separate out 
the effects of TAVI only or SAVR only. Separating these 
patients into the separate groups would be useful as SAVR 
involves general anaesthesia and thoracotomy while TAVI 
is percutaneous and only uses local anaesthesia. The 
different procedures might differ significantly in their 
short-term impact on patients. Post-SAVR patients might 
therefore respond differently to exercise-based CR, 
compared with post-TAVI patients. Not separating and 
analysing patients as distinct groups might therefore be 
a limitation to this study.
Our findings are consistent with the Cochrane system-
atic review by Sibilitz et al, who also evaluated the effects 
of exercise-based CR on exercise capacity in 148 patients 
(two studies) following heart valve surgery (RE RCT: 
SMD −0.47, 95% CI −0.81 to −0.13, in favour of exer-
cise).1 Sibilitz et al also found that this positive effect of 
CR did not reduce with time, as a statistically significant 
effect estimate was still seen at the longest follow-up of 12 
months (ie, RE RCT: SMD −0.50, 95% CI −0.85 to −0.14, 
in favour of exercise).1 Pressler et al recently reassessed 
17 patients at a mean of 24 months from baseline and 
found no preserved long-term improvements in VO2 max 
between both groups.7 However, they found that exer-
cise-based CR significantly improved submaximal exer-
cise capacity, which is possibly a better marker of aerobic 
efficiency and therefore more important in facilitating 
activities of daily living.7 Our 6MWT findings contrasts 
with the review by Ribeiro et al, who found that CR led 
to a statistically significant improvement in the 6MWT of 
862 patients (five studies) after TAVI or SAVR (RE: MD 
0.69, 95% CI 0.47 to 0.91).6 Although Ribeiro et al used 
a larger number of studies and participants, their find-
ings are limited as they failed to use non-CR controls to 
assess the comparative effect of CR on the 6MWT. The 
initial clinical benefits of exercise-based CR declines with 
a reduction in adherence to regular exercise.7 Therefore, 
ongoing exercise interventions are required for patients 
following TAVI or SAVR to maintain the initial improve-
ments in the long term.7
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Study strengths and limitations
Although this review adhered to the published protocol 
and to Cochrane guidelines, our study has some limita-
tions.
First, the major limitation was the limited evidence 
base: the number of included RCTs and non RCTs was 
small with a lack of consistent reporting of outcomes 
across studies. Second, although all studies were based 
on aerobic exercise training, there was considerable 
variation in the nature of exercise-based rehabilitation 
programmes across studies. Also, there were some differ-
ences in the populations (some studies looked at TAVI 
only, SAVR only and mixed populations). The compar-
ator of all the studies was no structured exercise, but 
in the Jairath study, standard care might have included 
receiving guidelines for activity after discharge. Also, no 
study fully detailed what usual care was, and it is possible 
that this might differ between studies. These factors are 
likely to have contributed to the statistical heterogeneity 
seen in the review. Third, although sensitivity analysis 
was carried out where statistical heterogeneity could not 
be determined by both I2 and the χ2 p value, the review 
did not consider sensitivity analysis for best or worse case 
scenarios, with regards to adverse events.1 This could 
give a guide to the potential impact on our results of not 
including participants with events due to poor descrip-
tion of drop outs. Fourth, the certainty of evidence of 
the included studies for the outcomes measured ranged 
from very low to high. This is largely influenced by risk 
of bias assessment and sample size. Overall, the sample 
sizes for most studies were low and the reporting bias in 
the studies made risk of bias assessment and therefore 
its impacts on our results very difficult. In spite of these 
limitations, this review included up-to-date studies, and 
a meta-analysis was also carried out where necessary, 
increasing its robustness.
Implications to current practice and future research
While in Europe and the USA, patients following myocar-
dial infarction and revascularisation and with heart failure 
can be offered CR; currently, such a policy is generally not 
the case for patients following open aortic valve surgery 
and TAVI.29 To inform future practice and policy, further 
evidence on the impact of CR following valve surgery is 
needed. Future studies of exercise-based CR post open 
aortic valve surgery or TAVI should aim to measure 
outcomes and costs that are relevant to the patients, clini-
cians and the policy makers. The studies should also aim 
to minimise bias and fully report all processes carried 
out. This would allow a more robust systematic review to 
be conducted, which would help inform recommenda-
tions for CR in TAVI and SAVR patients and therefore 
improve current practice.
CONCluSION
The results from this review show that exercise-based 
CR probably improves exercise capacity as measured by 
VO2 max. Other outcomes and safety of the intervention 
could not be fully appraised due to the small number 
of included RCTs and non-RCTs, small sample size and 
short study length. Further high-quality fully powered 
RCTs of longer follow-up are needed in order to defi-
nitely assess the effects of exercise-based CR in TAVI and 
SAVR patients. Such future studies should seek to collect 
patient relevant outcomes including HRQoL, mortality 
and hospitalisation.
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